Indolizines II: search for potential oral hypoglycemic agents

Area of Science:

• Medicinal Chemistry
• Pharmacology
• Organic Synthesis

Background:

• Indolizine ring is a core structure in some Vinca alkaloids with known biological activities.
• Hypoglycemic Vinca alkaloids like vincamine contain the indolizine moiety.
• Carcinolytic Vinca alkaloids such as vincristine and vinblastine also feature the indolizine structure.

Purpose of the Study:

• To synthesize and evaluate novel indolizine derivatives as potential oral hypoglycemic agents.
• To explore the structure-activity relationship of indolizines based on their presence in known Vinca alkaloids.
• To investigate the antineoplastic potential of synthesized indolizine compounds.

Main Methods:

• Synthesis of 1,2-bis(N-alkylaminomethyl)indolizines, indolizinecarboxylic acids, and 6-alkoxyindolizine-2-carboxylic acids.
• Screening of synthesized compounds for oral hypoglycemic activity in relevant models.
• Evaluation of antineoplastic activity of indolizine derivatives using Ehrlich ascites carcinoma model.

Main Results:

• Synthesized indolizine derivatives showed no significant hypoglycemic activity.
• The tested compounds did not validate the hypothesis of indolizines as structural leads for oral hypoglycemic agents.
• One synthesized indolizine derivative exhibited significant antineoplastic activity against Ehrlich ascites carcinoma.

Conclusions:

• Indolizine derivatives are not effective as oral hypoglycemic agents based on this study.
• The structural rationale for hypoglycemic activity based on Vinca alkaloids was not supported.
• Indolizine derivatives hold potential as antineoplastic agents, warranting further investigation.